Roivant Sciences Ltd (ROIV)

Sector:Health Care
Super Investor Stats:
Ownership count:2
Ownership rank:348
% of all portfolios:0.061%
Hold Price * :$11.54
History Portfolio Manager Activity Share change % change to portfolio ▲
Q3  2024
≡ David Einhorn - Greenlight Capital Add 10.33% 497,080 0.24
≡ Viking Global Investors Reduce 21.77% 15,056,780 0.63
Q2  2024
≡ Viking Global Investors Reduce 0.31% 213,115 0.01
≡ David Einhorn - Greenlight Capital Add 14.81% 620,470 0.32
Q1  2024
≡ David Einhorn - Greenlight Capital Buy 4,190,490 2.02
Q4  2023
≡ Viking Global Investors Reduce 5.54% 4,065,340 0.17
Q3  2023
≡ Viking Global Investors Reduce 2.40% 1,804,399 0.09
Q2  2023
≡ Viking Global Investors Reduce 14.73% 13,000,000 0.54
Q4  2021
≡ Viking Global Investors Buy 88,238,700 2.58

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.